For help on how to get the results you want, see our search tips.
303 results
Medicine
Orphan designations Remove Orphan designations filter
Maximum residue limits Remove Maximum residue limits filter
Withdrawn applications Remove Withdrawn applications filter
Summaries of opinion Remove Summaries of opinion filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Withdrawn Remove Withdrawn filter
-
List item
Veterinary medicine European public assessment report (EPAR): Zulvac 1 Bovis
inactivated bluetongue virus, serotype 1, Cattle
Date of authorisation: 05/08/2011,
, Revision: 7, Withdrawn, Last updated: 30/03/2020
-
List item
Human medicine European public assessment report (EPAR): Kromeya
adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 02/04/2019,
, 
, Revision: 4, Withdrawn, Last updated: 25/03/2020
-
List item
Human medicine European public assessment report (EPAR): Xiapex
collagenase Clostridium histolyticum, Dupuytren Contracture
Date of authorisation: 28/02/2011, Revision: 20, Withdrawn, Last updated: 02/03/2020 -
List item
Human medicine European public assessment report (EPAR): Varuby
rolapitant, Vomiting, Nausea, Cancer
Date of authorisation: 19/04/2017,, Revision: 3, Withdrawn, Last updated: 02/03/2020
-
List item
Human medicine European public assessment report (EPAR): Lifmior
etanercept, Arthritis, Psoriatic, Spondylitis, Ankylosing, Psoriasis
Date of authorisation: 13/02/2017, Revision: 8, Withdrawn, Last updated: 20/02/2020 -
List item
Human medicine European public assessment report (EPAR): Iblias
octocog alfa, Hemophilia A
Date of authorisation: 18/02/2016,, Revision: 4, Withdrawn, Last updated: 18/02/2020
-
List item
Human medicine European public assessment report (EPAR): Nonafact
human coagulation factor IX, Hemophilia B
Date of authorisation: 03/07/2001, Revision: 9, Withdrawn, Last updated: 18/02/2020 -
List item
Human medicine European public assessment report (EPAR): Zalmoxis
Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2), Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
Date of authorisation: 18/08/2016,
, Revision: 1, Withdrawn, Last updated: 14/02/2020
-
List item
Human medicine European public assessment report (EPAR): Fexeric
ferric citrate coordination complex, Hyperphosphatemia, Renal Dialysis
Date of authorisation: 23/09/2015,, Revision: 2, Withdrawn, Last updated: 04/02/2020
-
List item
Human medicine European public assessment report (EPAR): Aerivio Spiromax
salmeterol xinafoate, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 15/01/2020 -
List item
Human medicine European public assessment report (EPAR): Thorinane
enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 14/09/2016,, , Revision: 2, Withdrawn, Last updated: 24/10/2019
-
List item
Human medicine European public assessment report (EPAR): Imatinib medac
imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dermatofibrosarcoma, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myelodysplastic-Myeloproliferative Diseases, Hypereosinophilic Syndrome
Date of authorisation: 25/09/2013,
, Revision: 5, Withdrawn, Last updated: 16/10/2019
-
List item
Human medicine European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited )
docetaxel trihydrate, Stomach Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 28/08/2015,, Revision: 8, Withdrawn, Last updated: 15/10/2019
-
List item
Human medicine European public assessment report (EPAR): DepoCyte
cytarabine, Meningeal Neoplasms
Date of authorisation: 11/07/2001, Revision: 15, Withdrawn, Last updated: 07/10/2019 -
List item
Human medicine European public assessment report (EPAR): Lartruvo
Olaratumab, Sarcoma
Date of authorisation: 09/11/2016,
, , , , Revision: 3, Withdrawn, Last updated: 02/09/2019
-
List item
Human medicine European public assessment report (EPAR): Daklinza
daclatasvir dihydrochloride, Hepatitis C, Chronic
Date of authorisation: 22/08/2014,, Revision: 15, Withdrawn, Last updated: 30/08/2019
-
List item
Veterinary medicine European public assessment report (EPAR): Bovalto Ibraxion
inactivated IBR virus, Cattle
Date of authorisation: 09/03/2000, Revision: 10, Withdrawn, Last updated: 13/08/2019 -
List item
Human medicine European public assessment report (EPAR): Rituzena (previously Tuxella)
rituximab, Lymphoma, Non-Hodgkin, Microscopic Polyangiitis, Leukemia, Lymphocytic, Chronic, B-Cell, Wegener Granulomatosis
Date of authorisation: 13/07/2017,, , Revision: 7, Withdrawn, Last updated: 08/07/2019
-
List item
Human medicine European public assessment report (EPAR): ATryn
Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006,, 
, Revision: 16, Withdrawn, Last updated: 02/07/2019
-
List item
Human medicine European public assessment report (EPAR): Airexar Spiromax
salmeterol, fluticasone propionate, Pulmonary Disease, Chronic Obstructive, Asthma
Date of authorisation: 18/08/2016, Revision: 2, Withdrawn, Last updated: 02/07/2019 -
List item
Veterinary medicine European public assessment report (EPAR): Ingelvac PCV FLEX
porcine circovirus type 2 ORF2 protein, Pigs
Date of authorisation: 24/05/2017, Revision: 2, Withdrawn, Last updated: 28/06/2019 -
List item
Human medicine European public assessment report (EPAR): Macugen
pegaptanib, Wet Macular Degeneration
Date of authorisation: 31/01/2006, Revision: 15, Withdrawn, Last updated: 27/06/2019 -
List item
Human medicine European public assessment report (EPAR): Ketek
telithromycin, Sinusitis, Tonsillitis, Bronchitis, Chronic, Pharyngitis, Community-Acquired Infections, Pneumonia, Bacterial
Date of authorisation: 09/07/2001, Revision: 25, Withdrawn, Last updated: 19/06/2019 -
List item
Human medicine European public assessment report (EPAR): Arzerra
ofatumumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 19/04/2010, Revision: 16, Withdrawn, Last updated: 10/05/2019 -
List item
Veterinary medicine European public assessment report (EPAR): Parvoduk
live attenuated Muscovy duck parvovirus, Ducks
Date of authorisation: 11/04/2014, Revision: 2, Withdrawn, Last updated: 15/04/2019